We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
A summary of recent letters, medicine recalls and notifications sent to healthcare professionals.
A summary of recent letters and notifications sent to healthcare professionals about medicines.
Pfizer Ltd are recalling all in-date batches of Champix (varenicline) as a precautionary measure due to presence of levels of N-nitroso-varenicline above the acceptable level of intake. This recall also includes Parallel Imported/Distributed products.
The latest survey data from 2008 to 2012 assesses the food consumption and nutrient intake of the UK.
Lupin Healthcare (UK) Limited has informed us that the affected batches of Simvastatin tablets have been packaged with a version of patient information leaflet that does not include the most up to date safety information.
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.
Healthcare supplement company ordered into liquidation in the High Court after it was found to have taken advantage of elderly and vulnerable customers.
Be vigilant for any suspected adverse reactions associated with use of e-cigarettes or vaping (including lung injury) and report them to the MHRA via the Yellow Card scheme. In this article we provide UK case definitions of e-cigarette or vaping...
Toxic effects can occur with nitrous oxide especially with prolonged use.
How biofortified sweet potatoes are keeping pregnant women and young children healthy in Kenya
Recent epidemiological evidence of an increased risk of fracture with long-term use of proton pump inhibitors (PPIs).
A clinical trial has shown an increased risk of recurrent thrombotic events associated with rivaroxaban compared with warfarin, in patients with antiphospholipid syndrome and a history of thrombosis. Other direct-acting oral anticoagulants (DOACs) may be associated with a similarly increased...
The decision to grant approval for this treatment was endorsed by the government’s independent expert scientific advisory body, the Commission on Human Medicines, after carefully reviewing the evidence.
VetPlus are celebrating news that its sales in the Indian region have more than doubled following action from the Department of Business and Trade.
First published during the 2022 to 2024 Sunak Conservative government
Statement from Dr June Raine, MHRA Chief Executive, following the Joint Committee on Vaccination and Immunisation's new advice
The new antivirals could be rolled out through a clinical study from winter.
First published during the 2019 to 2022 Johnson Conservative government
Plans to add folic acid to flour in the UK could prevent up to 200 birth defects a year, Public Health Minister, Seema Kennedy, announced today.
First published during the 2016 to 2019 May Conservative government
This new vaccine, VidPrevtyn Beta, has been authorised after meeting the MHRA’s required safety, quality and effectiveness standards.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).